QA: Aclaris Therapeutics Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001557746_2021_Aclaris_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001557746, Aclaris Therapeutics Inc

  xvar xval
0 AssetsCurrent 57,493,000
1 IntangibleAssetsNetIncludingGoodwill 7,123,000
2 PropertyPlantAndEquipmentNet 1,654,000
3 remainder_Assets 4,514,000
4 LiabilitiesCurrent 14,874,000
5 LiabilitiesNoncurrent 3,179,000
6 remainder_Liabilities 15,081,000
7 CostOfGoodsAndServicesSold 4,889,338
8 SellingGeneralAndAdministrativeExpense 17,916,250
9 ResearchAndDevelopmentExpense 4,692,053
10 remainder_Expenses 4,205,242
11 remainder_Revenues 5,771,364
12 remainder_NetIncome -43,991,072
13 remainder_ComprehensiveNetIncome -28,202
  yvar yval
0 Assets 70,784,000
1 Liabilities 33,134,000
2 Expenses 31,702,883
3 Revenues 5,771,364
4 StockholdersEquity 37,650,000
5 NetIncome -69,922,591
6 ComprehensiveNetIncome -69,936,692
7 BaseVar 92,705,760
8 EconomicCapitalRatiobeforeLimitedLiability 0.234
9 EconomicCapitalRatio 1.64

Edgar->Model Mapping

Feature Distribution

Change over Time